{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:48:16Z","timestamp":1783601296860,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Cardiovascul diseases are the most common comorbidities in acromegaly. Potential parameters in pathology of cardiovascular comorbidities are changes in levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) as well as body composition parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The aim of this study was to examine morphological and functional parameters of the cardiovascular system by echocardiography and to assess its relationship with disease activity and body composition parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We prospectively enroled 129 acromegalic patients (82 females, 47 males) and 80 healthy controls (53 females, 27 males) matched for age, gender, and BMI. All patients underwent two-dimensional echocardiography. Body composition parameters were assessed by dual-energy X-ray absorptiometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Acromegaly patients presented with higher left ventricle mass (LVM) compared to controls (LVMI: 123\u2009\u00b1\u200945\u2009g\/m<jats:sup>2<\/jats:sup> vs 83\u2009\u00b1\u200916\u2009g\/m<jats:sup>2<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Prevalence of left ventricle hypertrophy in acromegaly patients was 67% (78% concentric, 22% eccentric). IGF -1 levels, BMI, and lean mass positively correlated with LVM in all acromegaly patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Fat mass positively correlated with LVM in females (<jats:italic>R<\/jats:italic>\u2009=\u20090.306, <jats:italic>P<\/jats:italic>\u2009=\u20090.005), but this correlation was not found in males. We did not find any difference in size of the left and right ventricle between acromegaly patients and controls. Acromegaly patients presented with left atrium enlargement, diastolic dysfunction and low incidence of systolic dysfunction. Valvopathy was found in 43% of patients with predominant (31%) prevalence of mitral regurgitation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study demonstrates higher prevalence of cardiovascular comorbidities in acromegaly patients and the impact of IGF-1 levels and body composition parameters in pathology in some of these comorbidities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-022-03232-3","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T06:02:36Z","timestamp":1667109756000},"page":"365-375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Filling the gap between the heart and the body in acromegaly: a case-control study"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9120-8867","authenticated-orcid":false,"given":"Ivana","family":"S\u00e1gov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Dragula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1n","family":"Mok\u00e1\u0148","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Va\u0148uga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"3232_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.33549\/physiolres.934681","volume":"70","author":"I S\u00e1gov\u00e1","year":"2021","unstructured":"I. S\u00e1gov\u00e1, D. P\u00e1vai, D. Kant\u00e1rov\u00e1, D. Holov\u00e1\u010dov\u00e1, M. Ku\u017ema, J. Payer, P. Va\u0148uga, Influence of disease activity and body composition parameters on cross sectional area of the median nerve in acromegalic patients. Physiol. Res. 70, 921\u2013929 (2021). https:\/\/doi.org\/10.33549\/physiolres.934681","journal-title":"Physiol. Res."},{"key":"3232_CR2","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1210\/jc.2009-0941","volume":"94","author":"A Colao","year":"2009","unstructured":"A. Colao, R.S. Auriemma, M. Galdiero, G. Lombardi, R. Pivonello, Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study. J. Clin. Endocrinol. Metab. 94, 3746\u20133756 (2009). https:\/\/doi.org\/10.1210\/jc.2009-0941","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3232_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/jrms.JRMS_955_18","volume":"24","author":"M Heidarpour","year":"2019","unstructured":"M. Heidarpour, D. Shafie, A. Aminorroaya, N. Sarrafzadegan, Z. Farajzadegan, R. Nouri, A. Najimi, C. Dimopolou, G. Stalla, Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review. J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci. 24, 29 (2019). https:\/\/doi.org\/10.4103\/jrms.JRMS_955_18","journal-title":"J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci."},{"key":"3232_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"89","author":"MR Gadelha","year":"2019","unstructured":"M.R. Gadelha, L. Kasuki, D.S. Lim, Systematic complications of acromegaly and impact of th current treatment landscape:an update. Endocr. Rev. 89, 268\u2013332 (2019). https:\/\/doi.org\/10.1210\/er.2018-00115","journal-title":"Endocr. Rev."},{"key":"3232_CR5","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz, J.A. Wass, Endocrine Society. Acromegaly: endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933\u20133951 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3232_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJM198710223171717","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"R.D. Mosteller, Simplified calculation of body-surface area. N. Engl. J. Med 317, 109 (1987). https:\/\/doi.org\/10.1056\/NEJM198710223171717","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"3232_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00004872-200305000-00001","volume":"21","author":"E O\u2019Brien","year":"2003","unstructured":"E. O\u2019Brien, R. Asmar, L. Beilin, Y. Imai, J.M. Mallion, G. Mancia et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 21(5), 821\u2013848 (2003). https:\/\/doi.org\/10.1097\/00004872-200305000-00001","journal-title":"J. Hypertens."},{"key":"3232_CR8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7326\/M15-3016","volume":"164","author":"JJ Chamberlain","year":"2016","unstructured":"J.J. Chamberlain, A.S. Rhinehart, C.F. Shaefer Jr, Neuman. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann. Intern. Med. 164, 542\u2013552 (2016). https:\/\/doi.org\/10.7326\/M15-3016","journal-title":"Ann. Intern. Med."},{"key":"3232_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J. Am. Soc. Echocardiogr. 28, 1\u201339 (2015). https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"6","key":"3232_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.echo.2007.02.034","volume":"20","author":"FH Jafary","year":"2007","unstructured":"F.H. Jafary, Devereux formula for left ventricular mass-be careful to use the right units of measurement. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 20(6), 783 (2007). https:\/\/doi.org\/10.1016\/j.echo.2007.02.034","journal-title":"J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr."},{"key":"3232_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"S.F. Nagueh, O.A. Smiseth, C.P. Appleton, B.F. Byrd 3rd, H. Dokainish, T. Edvardsen et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 29, 277\u2013314 (2016). https:\/\/doi.org\/10.1016\/j.echo.2016.01.011","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"3232_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/CRD.0000000000000215","volume":"26","author":"MD Goldberg","year":"2018","unstructured":"M.D. Goldberg, N. Vadera, S. Yandrapalli, W.H. Frishman, Acromegalic cardiomyopathy: and overview of risk factors, clinical manifestations and therapeutic options. Cardiol. Rev. 26, 307\u2013311 (2018). https:\/\/doi.org\/10.1097\/CRD.0000000000000215","journal-title":"Cardiol. Rev."},{"key":"3232_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1532-429X-10-S1-A347","volume":"68","author":"F Bogazzi","year":"2008","unstructured":"F. Bogazzi, M. Lombardi, E. Strata et al. High prevalence of cardiac hypertrophy without detectable signs of fibrosis in patients with untreated active acromegaly:an in vivo study using MRI. Clin. Endocrinol. 68, 361\u2013368 (2008). https:\/\/doi.org\/10.1186\/1532-429X-10-S1-A347","journal-title":"Clin. Endocrinol."},{"key":"3232_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"C. Semsarian, J. Ingles, M.S. Maron, B.J. Maron, New perspectives on the prevalence of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 65, 1249\u20131254 (2015). https:\/\/doi.org\/10.1016\/j.jacc.2015.01.019","journal-title":"J. Am. Coll. Cardiol."},{"key":"3232_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.14797\/mdcj-13-2-64","volume":"2","author":"MD Sharma","year":"2007","unstructured":"M.D. Sharma, A.V. Nguyen, S. Brown, R.J. Robbins, Cardiovascular disease in acromegaly. Huostonmethodist. org.\/debakey-J. 2, 64\u201367 (2007). https:\/\/doi.org\/10.14797\/mdcj-13-2-64","journal-title":"Huostonmethodist. org.\/debakey-J."},{"issue":"4","key":"3232_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1023\/b:pitu.0000023427.31609.a2","volume":"6","author":"MP Matta","year":"2003","unstructured":"M.P. Matta, P. Caron, Acromegalic cardiomyopathy: a review of the literature. Pituitary 6(4), 203\u2013207 (2003). https:\/\/doi.org\/10.1023\/b:pitu.0000023427.31609.a2","journal-title":"Pituitary"},{"key":"3232_CR17","doi-asserted-by":"publisher","first-page":"6935054","DOI":"10.1155\/2018\/6935054","volume":"11","author":"A Popielarz-Grygalewicz","year":"2018","unstructured":"A. Popielarz-Grygalewicz, J.S. G\u0105sior, A. Konwicka, P. Grygalewicz, M. Stelmachowska-Bana\u015b, W. Zgliczy\u0144ski, M. D\u0105browski, Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease. Int J. Endocrinol. 11, 6935054 (2018). https:\/\/doi.org\/10.1155\/2018\/6935054","journal-title":"Int J. Endocrinol."},{"issue":"12","key":"3232_CR18","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1210\/jc.2015-2675","volume":"100","author":"CM Dos Santos Silva","year":"2015","unstructured":"C.M. Dos Santos Silva, I. Gottlieb, I. Volschan et al. \u201cLow frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort\u201d. J. Clin. Endocrinol. Metab. 100(12), 4447\u20134455 (2015). https:\/\/doi.org\/10.1210\/jc.2015-2675","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3232_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ghir.2015.12.003","volume":"26","author":"PK Fazeli","year":"2016","unstructured":"P.K. Fazeli, G.J. Teoh, E.L. Lam et al. \u201cEffect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly\u201d. Growth Horm. IGF Res. 26, 17\u201323 (2016). https:\/\/doi.org\/10.1016\/j.ghir.2015.12.003","journal-title":"Growth Horm. IGF Res."},{"issue":"1","key":"3232_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/eurheartj\/14.1.26","volume":"14","author":"A Fazio","year":"1993","unstructured":"A. Fazio, D. Cittadini, A. Sabatini et al. \u201cEvidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.\u201d. Eur. Heart J. 14(1), 26\u201333 (1993). https:\/\/doi.org\/10.1093\/eurheartj\/14.1.26","journal-title":"Eur. Heart J."},{"issue":"8","key":"3232_CR21","first-page":"513","volume":"38","author":"D Fazio","year":"1993","unstructured":"D. Fazio, A. Sabatini, A. Cittadini et al. \u201cGrowth hormone and the heart\u201d. Cardiologia 38(8), 513\u2013518 (1993)","journal-title":"Cardiologia"},{"key":"3232_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/573643","volume":"2","author":"X Guo","year":"2015","unstructured":"X. Guo, L. Gao, S. Zhang et al. \u201cCardiovascular system changes and related risk factors in acromegaly patients: a case\u2013control study\u201d. Int. J. Endocrinol. 2, 1\u20137 (2015). https:\/\/doi.org\/10.1155\/2015\/573643","journal-title":"Int. J. Endocrinol."},{"key":"3232_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1590\/s0004-27302006000100012","volume":"50","author":"AF Casini","year":"2006","unstructured":"A.F. Casini, P.B. Araujo, R. Fontes, S.S. Xavier, M.R. Gadelha, Cardiac morphology and performance alterations and analysis of determinant factors of left ventricular hypertrophy in 40 patients with acromegaly. Arq. Bras. Endocrinol. Metab. 50, 82\u201390 (2006). https:\/\/doi.org\/10.1590\/s0004-27302006000100012","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"3232_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2265.2007.03047.x","volume":"68","author":"F Bogazzi","year":"2008","unstructured":"F. Bogazzi, M. Lombardi, E. Strata, G. Aquaro, V. Di Bello, C. Cosci et al. High prevalence of cardiac hypertrophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clin. Endocrinol. 68, 361\u2013368 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03047.x","journal-title":"Clin. Endocrinol."},{"key":"3232_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11102-007-0062-6","volume":"11","author":"L De Marinis","year":"2008","unstructured":"L. De Marinis, A. Bianchi, G. Mazziotti, M. Mettimano, D. Milardi, A. Fusco et al. The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 11, 13\u201320 (2008). https:\/\/doi.org\/10.1007\/s11102-007-0062-6","journal-title":"Pituitary"},{"key":"3232_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2265.2011.04019.x","volume":"75","author":"CN Jayasena","year":"2011","unstructured":"C.N. Jayasena, A.N. Comninos, H. Clarke, M. Donaldson, K. Meeran, W.S. Dhillo, The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Clin. Endocrinol. 75, 220\u2013225 (2011). https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04019.x","journal-title":"Clin. Endocrinol."},{"key":"3232_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1536\/ihj.53.299","volume":"53","author":"B Akdeniz","year":"2012","unstructured":"B. Akdeniz, A. Gedik, O. Turan, E. Ozpelit, A.O. Ikiz, O. Itil et al. Evaluation of left ventricular diastolic function according to new criteria and determinants in acromegaly. Int Heart J. 53, 299\u2013305 (2012). https:\/\/doi.org\/10.1536\/ihj.53.299","journal-title":"Int Heart J."},{"key":"3232_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2265.2012.04472.x","volume":"78","author":"GC Nascimento","year":"2013","unstructured":"G.C. Nascimento, M.T. de Oliveira, V.C. Carvalho, M.H. Lopes, Guimares Sa\u0301 AM, Souza MT, et al. Acromegalic cardiomyopathy in an extensively admixed population: is there a role for GH\/IGF-1 axis? Clin. Endocrinol. (Oxf.) 78, 94\u2013101 (2013). https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04472.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"3232_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.endonu.2015.05.007","volume":"62","author":"R Sanchez-Ortiga","year":"2015","unstructured":"R. Sanchez-Ortiga, V. Climent, L. Sanchez-Tejada, A. Candela, A. Pico, Severe sleep apnea-hypopnea syndrome is related to left ventricle dysfunction and hypertrophy in acromegalic patients. Endocrinol. Nutr. 62, 366\u2013372 (2015). https:\/\/doi.org\/10.1016\/j.endonu.2015.05.007","journal-title":"Endocrinol. Nutr."},{"key":"3232_CR30","doi-asserted-by":"publisher","unstructured":"X. Guo, L. Gu, S. Zhang, Y. Li, Y. Wu, L. Fang, et al. Cardiovascular system changes and related risk factors in acromegaly patients: a case-control study. Int. J. Endocrinol. (2015). https:\/\/doi.org\/10.1155\/2015\/573643","DOI":"10.1155\/2015\/573643"},{"key":"3232_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1530\/EJE-15-0500","volume":"173","author":"E Kuhn","year":"2015","unstructured":"E. Kuhn, L. Maione, A. Bouchachi, M. Rozi\u00e8re, S. Salenave, S. Salenave et al. Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study. Eur. J. Endocrinol. 173, 693\u2013702 (2015). https:\/\/doi.org\/10.1530\/EJE-15-0500","journal-title":"Eur. J. Endocrinol."},{"key":"3232_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4158\/EP161637.OR","volume":"23","author":"GB Cansu","year":"2017","unstructured":"G.B. Cansu, N. Yilmaz, A. Yan\u0131kog\u0306lu, S. \u00d6zdem, A.B. Y\u0131ld\u0131r\u0131m, G. S\u00fcleymanlar et al. Assessment of diastolic dysfunction, arterial stiffness, and carotid intima-media thickness in patients with acromegaly. EndocrPract 23, 536\u2013545 (2017). https:\/\/doi.org\/10.4158\/EP161637.OR","journal-title":"EndocrPract"},{"key":"3232_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12902-017-0166-6","volume":"17","author":"JD Carmichael","year":"2017","unstructured":"J.D. Carmichael, M.S. Broder, D. Cherepanov, E. Chang, A. Mamelak, Q. Said et al. The association between biochemical control and cardiovascular risk factors in acromegaly. BMC EndocrDisord 17, 15 (2017). https:\/\/doi.org\/10.1186\/s12902-017-0166-6","journal-title":"BMC EndocrDisord"},{"issue":"1","key":"3232_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4183\/aeb.2019.52","volume":"15","author":"E Natchev","year":"2019","unstructured":"E. Natchev, A. Kundurdjiev, N. Zlatareva, S. Vandeva, G. Kirilov, T. Kundurzhiev et al. Echocardiographic myocardial changes in acromegaly: a crosssectional analysis in a tertiary center bulgaria. Endocr. Care 15(1), 52\u201361 (2019). https:\/\/doi.org\/10.4183\/aeb.2019.52","journal-title":"Endocr. Care"},{"key":"3232_CR35","doi-asserted-by":"publisher","unstructured":"X. Guo, J. Cao, P. Liu, Y. Cao, X. Li, T. Kundurzhiev, et al. Cardiac abnormalities in acromegaly patients: a cardiac magnetic resonance study. Int. J. Endocrinol. (2020). https:\/\/doi.org\/10.1155\/2020\/2018464","DOI":"10.1155\/2020\/2018464"},{"issue":"5","key":"3232_CR36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1210\/edrv-15-5-555","volume":"15","author":"L Sacc\u00e0","year":"1994","unstructured":"L. Sacc\u00e0, A. Cittadini, S. Fazio, Growth hormone and the heart. Endocr. Rev. 15(5), 555\u2013573 (1994). https:\/\/doi.org\/10.1210\/edrv-15-5-555","journal-title":"Endocr. Rev."},{"issue":"5","key":"3232_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1530\/EJE-11-0408","volume":"165","author":"A Colao","year":"2011","unstructured":"A. Colao, R. Pivonello, L.F. Grasso, R.S. Auriemma, M. Galdiero, S. Savastano et al. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 years\u2019 survey study. Eur. J. Endocrinol. 165(5), 713\u2013721 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0408","journal-title":"Eur. J. Endocrinol."},{"key":"3232_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1039\/oby.2011.101","volume":"20","author":"D Kardassis","year":"2012","unstructured":"D. Kardassis, O. Bech-Hanssen, M. Schonander, L. Sjostrom, K. Karason, The influence of body composition, fat distribution, and sustained weight loss on left ventricular mass and geometry in obesity. Obes. (Silver Spring) 20, 605\u2013611 (2012). https:\/\/doi.org\/10.1039\/oby.2011.101","journal-title":"Obes. (Silver Spring)"},{"key":"3232_CR39","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1097\/HJH.0b013e328347a093","volume":"29","author":"G de Simone","year":"2011","unstructured":"G. de Simone, R.B. Devereux, M. Chinali, M.J. Roman, A. Barac, J.A. Panza, E.T. Lee, B.V. Howard, Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study. J. Hypertens. 29, 1431\u20131438 (2011). https:\/\/doi.org\/10.1097\/HJH.0b013e328347a093","journal-title":"J. Hypertens."},{"issue":"3","key":"3232_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcmg.2009.10.012","volume":"3","author":"EB Turkbey","year":"2010","unstructured":"E.B. Turkbey, R.L. McClelland, R.A. Kronmal, G.L. Burke, D.E. Bild, R.P. Tracy, A.E. Arai, J.A. Lima, D.A. Bluemke, The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging 3(3), 266\u2013274 (2010). https:\/\/doi.org\/10.1016\/j.jcmg.2009.10.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"3232_CR41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.amjcard.2013.04.030","volume":"112","author":"SA Maskatia","year":"2013","unstructured":"S.A. Maskatia, J.A. Spinner, A.C. Nutting et al. Impact of obesity on ventricular size and function in children, adolescents and adults with tetralogy of fallot after initial repair. Am. J. Cardiol. 112, 594\u2013598 (2013). https:\/\/doi.org\/10.1016\/j.amjcard.2013.04.030","journal-title":"Am. J. Cardiol."},{"key":"3232_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ijcard.2012.09.055","volume":"168","author":"G de Simone","year":"2013","unstructured":"G. de Simone, F. Pasanisi, A.L. Ferrara, M.J. Roman, E.T. Lee, F. Contaldo, B.V. Howard, R.B. Devereux, Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. Int J. Cardiol. 168, 729\u2013733 (2013). https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.055","journal-title":"Int J. Cardiol."},{"issue":"4","key":"3232_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/eurheartj\/ehs341","volume":"34","author":"OJ Rider","year":"2013","unstructured":"O.J. Rider, A. Lewandowski, R. Nethononda, S.E. Petersen, J.M. Francis, A. Pitcher et al. Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging. Eur. Heart J. 34(4), 292\u2013299 (2013). https:\/\/doi.org\/10.1093\/eurheartj\/ehs341","journal-title":"Eur. Heart J."},{"issue":"1","key":"3232_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1532-429X-16-16","volume":"16","author":"A de Marvao","year":"2014","unstructured":"A. de Marvao, T.J. Dawes, W. Shi, C. Minas, N.G. Keenan, T. Diamond et al. Population-based studies of myocardial hypertrophy: high resolution cardiovascular magnetic resonance atlases improve statistical power. J. Cardiovasc Magn. Reson 16(1), 16 (2014). https:\/\/doi.org\/10.1186\/1532-429X-16-16","journal-title":"J. Cardiovasc Magn. Reson"},{"key":"3232_CR45","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11102-015-0657-2","volume":"18","author":"TJ Reid","year":"2015","unstructured":"T.J. Reid, Z. Jin, W. Shen, C.M. Reyes-Vidal, J.C. Fernandez, J.N. Bruce, J. Kostadinov, K.D. Post, P.U. Freda, IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition. Pituitary 18, 808\u2013819 (2015). https:\/\/doi.org\/10.1007\/s11102-015-0657-2","journal-title":"Pituitary"},{"issue":"11","key":"3232_CR46","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1210\/jc.2017-01210","volume":"102","author":"MA Breella","year":"2017","unstructured":"M.A. Breella, M. Schorr, L.E. Dichtel, A.V. Gerweck, B.J. Young, W.W. Woodmansee, B. Swearingen, K.K. Miller, Body composition and ectopic lipid changes with biochemical control of acromegaly. J. Clin. Endocrinol. Metab. 102(11), 4218\u20134225 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01210","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3232_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/EJE-17-0120","volume":"177","author":"L F\u00fcchtbauer","year":"2017","unstructured":"L. F\u00fcchtbauer, D.S. Olsson, B.\u00c5. Bengtsson, L.L. Norrman, K.S. Sunnerhagen, G. Johannsson, Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up. Eur. J. Endocrinol. 177(2), 217\u2013226 (2017). https:\/\/doi.org\/10.1530\/EJE-17-0120","journal-title":"Eur. J. Endocrinol."},{"key":"3232_CR48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijcard.2014.01.074","volume":"172","author":"CY Liu","year":"2014","unstructured":"C.Y. Liu, D.A. Bluemke, G. Gerstenblith, S.L. Zimmerman, J. Li, H. Zhu, S. Lai, H. Lai, Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans. Int J. Cardiol. 172, 381\u2013387 (2014). https:\/\/doi.org\/10.1016\/j.ijcard.2014.01.074","journal-title":"Int J. Cardiol."},{"issue":"1","key":"3232_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","volume":"6","author":"EB Geer","year":"2009","unstructured":"E.B. Geer, W. Shen, Gender differences in insulin resistance, body composition, and energy balance. Gend. Med 6(1), 60\u201375 (2009). https:\/\/doi.org\/10.1016\/j.genm.2009.02.002","journal-title":"Gend. Med"},{"issue":"5","key":"3232_CR50","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/CIRCIMAGING.113.000532","volume":"6","author":"IJ Neeland","year":"2013","unstructured":"I.J. Neeland, S. Gupta, C.R. Ayers, A.T. Turer, J.E. Rame, S.R. Das et al. Relation of regional fat distribution to left ventricular structure and function. Circ. Cardiovasc Imaging 6(5), 800\u2013807 (2013). https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000532","journal-title":"Circ. Cardiovasc Imaging"},{"issue":"1","key":"3232_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12968-016-0251-4","volume":"18","author":"B Corden","year":"2016","unstructured":"B. Corden, A. de Marvao, T.J. Dawes, W. Shi, D. Rueckert, S.A. Cook, D.P. O\u2019Regan, Relationship between body composition and left ventricular geometry using three-dimensional cardiovascular magnetic resonance. J. Cardiovasc Magn. Reson 18(1), 32 (2016). https:\/\/doi.org\/10.1186\/s12968-016-0251-4. May 31","journal-title":"J. Cardiovasc Magn. Reson"},{"key":"3232_CR52","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fendo.2020.00418","volume":"11","author":"B Uzi\u0229b\u0142o-\u017byczkowska","year":"2020","unstructured":"B. Uzi\u0229b\u0142o-\u017byczkowska, A. Jurek, P. Witek et al. Left heart dysfunction in acromegaly revealed by novel echocardiographic methods. Front. Endocrinol. 11, 418 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.00418","journal-title":"Front. Endocrinol."},{"key":"3232_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2265.2012.04472.x","volume":"78","author":"GC Nascimento","year":"2013","unstructured":"G.C. Nascimento, M.T. de Oliveira, V.C. Carvalho, M.H. Lopes, A.M. Guimares Sa\u0301 et al. Acromegalic cardiomyopathy in an extensively admixed population: is there a role for GH\/IGF-1 axis? Clin. Endocrinol. 78, 94\u2013101 (2013). https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04472.x","journal-title":"Clin. Endocrinol."},{"key":"3232_CR54","doi-asserted-by":"publisher","first-page":"536","DOI":"10.4158\/EP161637.OR","volume":"23","author":"GB Cansu","year":"2017","unstructured":"G.B. Cansu, N. Yilmaz, A. Yan\u0131kog\u0306lu, S. \u00d6zdem, A.B. Y\u0131ld\u0131r\u0131m, G. S\u00fcleymanlar et al. Assessment of diastolic dysfunction, arterial stiffness, and carotid intima-media thickness in patients with acromegaly. EndocrPract 23, 536\u2013545 (2017). https:\/\/doi.org\/10.4158\/EP161637.OR","journal-title":"EndocrPract"},{"issue":"1","key":"3232_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4183\/aeb.2019.52","volume":"15","author":"E Natchev","year":"2019","unstructured":"E. Natchev, A. Kundurdjiev, N. Zlatareva, S. Vandeva, G. Kirilov, T. Kundurzhiev et al. Echocardiographic myocardial changes in acromegaly: a crosssectional analysis in a tertiary center bulgaria. Endocr. Care 15(1), 52\u201361 (2019). https:\/\/doi.org\/10.4183\/aeb.2019.52","journal-title":"Endocr. Care"},{"issue":"3","key":"3232_CR56","first-page":"77","volume":"29","author":"G Vitale","year":"2004","unstructured":"G. Vitale, R. Pivonello, G. Lombardi, A. Colao, Cardiovascular complications in acromegaly. Minerva Endocrinol. 29(3), 77\u201388 (2004)","journal-title":"Minerva Endocrinol."},{"key":"3232_CR57","unstructured":"M. Kr\u0161ek, Endokrinni choroby a jejich vliv na KV system, vol. 17. (Medical Tribune, 2015)"},{"key":"3232_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1210\/jc.2003-030849","volume":"89","author":"AM Pereira","year":"2004","unstructured":"A.M. Pereira, S.W. van Thiel, J.R. Lindner, F. Roelfsema et al. Increased prevalence of regurgitant valvular heart disease in acromegaly. J. Clin. Endocrinol. Metab. 89, 71\u201375 (2004). https:\/\/doi.org\/10.1210\/jc.2003-030849","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"3232_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.11969\/j.issn.1673-548X.2018.08.003","volume":"47","author":"XP Guo","year":"2018","unstructured":"X.P. Guo, B. Xing, Progress in magnetic resonance research on heart disease in patients with acromegaly. J. Med Res 47(8), 7\u201310 (2018). https:\/\/doi.org\/10.11969\/j.issn.1673-548X.2018.08.003","journal-title":"J. Med Res"},{"key":"3232_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ghir.2006.02.002","volume":"16","author":"AA van der Klaauw","year":"2006","unstructured":"A.A. van der Klaauw, J.J. Bax, F. Roelfsema, G.B. Bleeker, E.R. Holman, E.P. Corssmit et al. Uncontrolled acromegaly is associated with progressive mitral valvular regurgitation. Growth Horm. IGF Res. 16, 101\u2013107 (2006). https:\/\/doi.org\/10.1016\/j.ghir.2006.02.002","journal-title":"Growth Horm. IGF Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03232-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:46:26Z","timestamp":1675309586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03232-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["3232"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03232-3","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]},"assertion":[{"value":"2 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}